Integrated Traditional Chinese and Western Medicine Therapy for Myocardial Infarction
Abstract
Myocardial infarction (MI) is an acute and critical cardiovascular disease characterized by acute myocardial ischemia and necrosis due to coronary artery occlusion. It has the characteristics of high morbidity, rapid progression, and high mortality, seriously threatening human life and health. Western medicine has mature treatment systems for MI, such as reperfusion therapy, antiplatelet aggregation, and lipid-lowering therapy, which can quickly relieve acute symptoms but have limitations in improving long-term prognosis and reducing complications. Traditional Chinese Medicine (TCM), based on the holistic concept and syndrome differentiation and treatment, has unique advantages in regulating qi and blood, unblocking collaterals, and promoting myocardial repair. Integrated Traditional Chinese and Western Medicine (TCM-WM) therapy combines the advantages of both, complementing each other to optimize the treatment effect.
References
[2]ZhaoZ ,Wang X ,Wang S , et al. Study on the clinical assessment of integrated rehabilitation of Traditional Chinese Medicine and western medication for acute myocardial infarction[J].Medicine,2020,99(34):e21592-e21592.
[3]Lei W ,Minzhou Z ,Liheng G , et al. Clinical pathways based on integrative medicine in chinese hospitals improve treatment outcomes for patients with acute myocardial infarction: a multicentre, nonrandomized historically controlled trial.[J].Evidence-based complementary and alternative medicine: eCAM,2012,2012821641.
Yibo Research & Academic Press is committed to safeguarding authors' copyrights and all related information, ensuring these rights are fully protected by law. Whether you choose to publish your articles with our press or not, we require every employee to adhere to the highest ethical standards in the industry, assume responsibilities, and fulfill legal obligations.
To further protect authors' rights, we provide detailed information on copyright agreements on our official website for your reference. Regarding the reuse rights of articles, Yibo Research & Academic Press maintains an open attitude and strictly complies with the CC BY-NC 4.0 publication guidelines. This guideline not only provides copyright protection for authors but also meets the standards for usage rights set by the Open Access Scholarly Publishing Association (OASPA).
For authors who wish to further protect their articles, we also offer the CC BY-NC guideline service. Based on the CC guideline selected by the author, the original copyright and reuse rights of the article will be clearly stated in the article. This approach not only respects the authors' intellectual property rights but also promotes the reasonable dissemination and use of academic achievements.